In its scientific opinion, the Authority noted that the absence of the genotoxic substance furan-2(5H)-one from Fumokomp (SF-009) was not convincingly demonstrated and that the whole mixture testing in an in vitro mouse lymphoma assay gave positive results which would require an adequate in vivo follow-up study. In addition, the Authority considered that the potential for aneugenicity of Fumokomp (SF-009) had not been adequately investigated. Accordingly, the Authority concluded that the potential safety concern for genotoxicity of Fumokomp (SF-009) cannot be ruled out.
Recital 5, Decision_act (EU) 2024/2077
In forcesince 31 Jul 2024